REZOLUTE, INC. Other Current Assets
REZOLUTE, INC. (RZLT) had Other Current Assets of $13.99 thousand as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2019-05-10
- 2019-03-31: Other Assets, Current $13.99K.
- 2018-12-31: Other Assets, Current $91.55K.
- 2018-09-30: Other Assets, Current $372.11K.
- 2018-06-30: Other Assets, Current $361.92K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2019-03-31 | $13.99K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $91.55K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $372.11K 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $361.92K 10-Q · filed 2019-05-10 | |
| 2018-03-31 | $367.81K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $295.73K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $349.17K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $442.01K 10-K · filed 2018-10-15 | |
| 2017-03-31 | $413.04K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $213.44K 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $363.80K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $430.09K 10-K · filed 2017-09-22 | |
| 2016-03-31 | $294.28K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $134.77K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $64.67K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $387.51K 10-K · filed 2016-09-28 | $320.29K 10-K · filed 2015-09-28 |
| 2015-03-31 | $175.02K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $66.79K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $95.88K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $83.42K 10-K · filed 2015-09-28 | |
| 2014-03-31 | $119.80K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $13.97K 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $50.22K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $95.47K 10-K · filed 2014-09-30 | |
| 2013-03-31 | $369.74K 10-Q · filed 2013-05-15 | |
| 2012-06-30 | $102.17K 10-K · filed 2013-09-11 | $178.68K 10-Q · filed 2013-05-15 |
| 2011-12-31 | $100.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |